The NCRI Lymphoma Science subgroup brings together a multidisciplinary group of lymphoma researchers, including basic, translational and clinical scientists from 14 research centres around the UK, to develop and support lymphoma research and researchers with the goal of improving outcomes for patients with these diseases.
Members are competitively recruited, and subgroups meet at least twice a year.

Jude Fitzgibbon

Professor Jude Fitzgibbon

(Chair)

Group leader & Scientist PhD, Queen Mary University of London

Other subgroup alignment ...

Professor Jude Fitzgibbon

(Chair)

Group leader & Scientist PhD, Queen Mary University of London

Other subgroup alignment: Low and high grade

Disease interest: FL, DLBCL

Key research areas: Biomarkers, epigenetics, drug targets

Core funding: CRUK

cathy burton

Dr Cathy Burton

(Deputy Chair)

Consultant Haematologist, St James’s University Hospital, Leeds

Other subgroup align ...

Dr Cathy Burton

(Deputy Chair)

Consultant Haematologist, St James’s University Hospital, Leeds

Other subgroup alignment: Hodgkin’s and high grade

Disease interest: HL, DLBCL

Key research areas: Diagnostics, biomarkers

Professor Andrew Pettitt

Professor Andrew Pettitt

Professor of Haemato-oncology, University of Liverpool & Clatterbridge Cancer Centre NHS Foun ...

Professor Andrew Pettitt

Professor of Haemato-oncology, University of Liverpool & Clatterbridge Cancer Centre NHS Foundation Trust

Other subgroup alignment: Low-grade NHL, CLL, Haem ECMC group

Disease interest: FL, CLL

Key research areas: Clinical trials, biobanking, p53 pathway, biomarkers

Core funding: CRUK, Blood Cancer UK

Kim Linton

Dr Kim Linton

Consultant Medical Oncologist & Clinical Senior Lecturer, The Christie NHS Foundation Trust a ...

Dr Kim Linton

Consultant Medical Oncologist & Clinical Senior Lecturer, The Christie NHS Foundation Trust and The University of Manchester

Other subgroup alignment: Chair of low-grade lymphoma subgroup, low and high grade

Disease interest: FL, MCL, MZL, WM, HL, PCNSL, DLBCL and HL

Key research areas: Clinical drug development, biomarkers, late effects

Core funding: Blood Cancer UK and the Roy Castle Lung Cancer Foundation

Dr Christopher Fox

Consultant Haematologist, Nottingham University Hospitals

Other subgroup alignment: Chair ...

Dr Christopher Fox

Consultant Haematologist, Nottingham University Hospitals

Other subgroup alignment: Chair of high-grade lymphoma subgroup, High grade

Disease interest: DLBCL, PTCL, CNS lymphoma

Key research areas: early and late phase trials, biomarkers

Dr Graham Collins

Dr Graham Collins

Consultant Haematologist, Oxford University Hospitals

Other subgroup alignment: Chair of h ...

Dr Graham Collins

Consultant Haematologist, Oxford University Hospitals

Other subgroup alignment: Chair of hodgkins lymphoma subgroup, hodgkin and high grade; haem ECMC group

Disease interest: Hodgkin, DLBCL, T-cell lymphoma

Key research areas: early phase trials, cell free DNA

Dr Sean Lim

Dr Sean Lim

Group leader & Consultant in Haematological Oncology, University of Southampton

Other ...

Dr Sean Lim

Group leader & Consultant in Haematological Oncology, University of Southampton

Other subgroup alignment: High grade

Disease interest: DLBCL, PTCL

Key research areas: Antibodies, cancer immunology, novel agents

Core funding: CRUK

Dr Simon Bomken

Dr Simon Bomken

Group leader & Consultant Paediatric Oncologist, Newcastle University

Other subgroup a ...

Dr Simon Bomken

Group leader & Consultant Paediatric Oncologist, Newcastle University

Other subgroup alignment: Paediatric non-Hodgkin lymphoma

Disease interest: Burkitt, DLBCL, PTLD/immunodysregulation and LPD

Key research areas: Genomic evolution, therapy resistance, PDX modelling

Core funding: MRC

Professor Tim Illidge

Professor Tim Illidge

Group leader & Consultant Oncologist, University of Manchester, Christie NHS Foundation Trust ...

Professor Tim Illidge

Group leader & Consultant Oncologist, University of Manchester, Christie NHS Foundation Trust

Other subgroup alignment: Low grade and High grade

Disease interest: FL, HL, PTCL, CTCL

Key research areas: Immunoregulatory agents, tumour immunology, radiotherapy, antibodies

Professor Ruth Jarrett

Professor Ruth Jarrett

Professor of Molecular Pathology, University of Glasgow

Other subgroup alignment: Hodgkin< ...

Professor Ruth Jarrett

Professor of Molecular Pathology, University of Glasgow

Other subgroup alignment: Hodgkin

Disease interest: Hodgkin, virus-associated lymphomas

Key research areas: Hodgkin lymphoma biology, HL biomarkers, viruses and lymphomas, have a cell bank of viable lymphoma samples

Dr Sharon Barrans

Dr Sharon Barrans

Clinical Scientist, HMDS St James’s University Hospital, Leeds

Disease interest: DLB ...

Dr Sharon Barrans

Clinical Scientist, HMDS St James’s University Hospital, Leeds

Disease interest: DLBCL, Burkitt

Key research areas: Diagnostics, gene expression, FISH, biomarkers

Professor Nagesh Kalakonda

Professor Nagesh Kalakonda

Experimental Haematology, University of Liverpool.
Honorary Consultant,  Haemato-oncology< ...

Professor Nagesh Kalakonda

Experimental Haematology, University of Liverpool.
Honorary Consultant,  Haemato-oncology
The Clatterbridge Cancer Centre

Other subgroup alignment: High grade NHL

Disease interests: High grade lymphomas, TYA Cancers

Key research areas: Epigenetics, cancer resistance, mass cytometry

Dr Christopher Carey

Clinical Research Fellow & Honorary Consultant Haematologist,
University of Newcastle

Dr Christopher Carey

Clinical Research Fellow & Honorary Consultant Haematologist,
University of Newcastle

Disease interest: CHL, High grade B-cell NHL

Key research areas: Diagnostics, biomarkers, computational pathology

Core funding: University of Newcastle

Dr Daniel Hodson

Research Group Leader & Honorary Consultant Haematologist,
Wellcome-MRC Cambridge Stem ...

Dr Daniel Hodson

Research Group Leader & Honorary Consultant Haematologist,
Wellcome-MRC Cambridge Stem Cell Institute

Other subgroup alignment: High grade

Disease interest: DLBCL

Key research areas: Functional Genomics, genetics, novel lymphoma models

Core funding: MRC

Professor Andrew Davies

Professor of Haematological Oncology,
University of Southampton

Other subgroup align ...

Professor Andrew Davies

Professor of Haematological Oncology,
University of Southampton

Other subgroup alignment: High-Grade

Key research areas: Translational, biomarkers, novel therapeutics

Core funding: CRUK, Blood Cancer UK

Dr Jessica Okosun

Group Leader & Consultant Haematologist,
Queen Mary University of London

Other s ...

Dr Jessica Okosun

Group Leader & Consultant Haematologist,
Queen Mary University of London

Other subgroup alignment: Low and high grade

Disease interest: FL, PCNSL, DLBCL

Key research areas: Biomarkers, multi-omics, liquid biopsy, big data

Core funding: CRUK

Professor Sally Barrington

Professor of PET Imaging,
Kings College London

Other subgroup alignment: Hodgkins, l ...

Professor Sally Barrington

Professor of PET Imaging,
Kings College London

Other subgroup alignment: Hodgkins, low and high grade

Disease interest: Imaging related to HL, DLBCL, FL

Key research areas: PET Imaging

Core funding: NIHR

Professor Ming-Qing Du

Group leader & molecular pathologist,
University of Cambridge/Addenbrooke’s Hospi ...

Professor Ming-Qing Du

Group leader & molecular pathologist,
University of Cambridge/Addenbrooke’s Hospital

Other subgroup alignment: High grade

Disease interest: DLBCL, marginal zone lymphoma, AITL/PTCL- TFH

Key research areas: Molecular pathology, genetics, biomarker, drug targets

Core funding: Blood Cancer UK, CRUK, KKLF

Dr Matthew Ahearne

Consultant Haematologist,
University Hospitals of Leicester/University of Leicester

...

Dr Matthew Ahearne

Consultant Haematologist,
University Hospitals of Leicester/University of Leicester

Other subgroup alignment: T-cell lymphoma group

Disease interest: PTCL, DLBCL

Key research areas: ctDNA, molecular diagnostics, T-cell biology

Dr Martin Turner

Head of Programme/Department,
The Babraham Institute

Disease interest: Lymphoma

...

Dr Martin Turner

Head of Programme/Department,
The Babraham Institute

Disease interest: Lymphoma

Key research areas: Cell-cell communication and the regulation of gene expression

Core funding: BBSRC

Dr Simon Mitchell

Group leader & Lecturer in Cancer Research,
University of Sussex / Brighton and Sussex ...

Dr Simon Mitchell

Group leader & Lecturer in Cancer Research,
University of Sussex / Brighton and Sussex Medical School

Disease interest: DLBCL

Key research areas: Systems/computational biology, biomarkers, drug targets

Core funding: Leukaemia UK & UKRI Future Leaders Fellowship

Dr Malcolm Rhodes

Retired industry biotechnologist; production of biologics; R&D Director.

FL patient in ...

Dr Malcolm Rhodes

Retired industry biotechnologist; production of biologics; R&D Director.

FL patient in 1st remission

Other subgroup alignment: Low Grade

Key research areas: real-time monitoring of disease; accelerating adoption of new technologies and treatments

Dr David Donaldson

Consultant Haematologist with special interest in Lymphoma/Myeloma, Belfast City Hospital

Dr David Donaldson

Consultant Haematologist with special interest in Lymphoma/Myeloma, Belfast City Hospital

Disease interest: Low grade lymphoma

Key research areas: CLL